In the last week, the United States market has remained flat, yet it has experienced a 20% increase over the past year with earnings projected to grow by 17% annually in the coming years. In this context of robust growth expectations, identifying high-growth companies with strong insider ownership can offer insights into businesses where those closest to the company have significant confidence in its future prospects.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
Uxin (UXIN)	34.3%	69.4%
Upstart Holdings (UPST)	13.9%	66.5%
Precigen (PGEN)	11.7%	55.4%
Karman Holdings (KRMN)	14.9%	54%
Himax Technologies (HIMX)	29.2%	70.2%
Dave (DAVE)	17.2%	23%
Carlyle Group (CG)	27.5%	20.5%
Astera Labs (ALAB)	10%	33.2%
AppLovin (APP)	23.3%	20.6%
Almonty Industries (ALM)	10.8%	37.1%

Let's uncover some gems from our specialized screener.

AppFolio (APPF)

Simply Wall St Growth Rating: ★★★★★☆

Overview: AppFolio, Inc. offers a cloud-based platform tailored for the real estate industry in the United States and has a market capitalization of approximately $7.22 billion.

Operations: The company generates revenue from its cloud-based business management software and Value+ platforms, totaling approximately $1.04 billion.

Insider Ownership: 26.7%

Earnings Growth Forecast: 22.9% p.a.

AppFolio is experiencing robust growth, with earnings forecasted to rise significantly at 22.9% annually, surpassing the US market's average. Despite a recent decline in profit margins from 23.5% to 15.1%, insider ownership remains strong, with more shares bought than sold recently. The company’s collaboration with Amazon Web Services enhances its AI capabilities and platform reliability, supporting its vision for Real Estate Performance Management and driving innovation across its product offerings.

Accelerant Holdings (ARX)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Accelerant Holdings operates a data-driven risk exchange that connects specialty insurance underwriters with risk capital partners, and has a market cap of $4.25 billion.

Operations: The company's revenue segments include $480.60 million from underwriting, $256.90 million from MGA operations, and $385.90 million from exchange services.

Insider Ownership: 25.5%

Earnings Growth Forecast: 138.9% p.a.

Accelerant Holdings is poised for growth, with earnings projected to grow at 138.87% annually, outpacing market averages. Despite recent insider selling, the company retains substantial insider ownership and has completed a significant share buyback program worth US$77.35 million. Recent earnings reports show impressive revenue and net income increases year-over-year, while strategic partnerships with Lloyd’s of London and others bolster its specialty insurance portfolio. An acquisition by Thoma Bravo valued at over US$4 billion highlights investor confidence in Accelerant's platform.

Shift4 Payments (FOUR)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Shift4 Payments, Inc. provides software and payment processing solutions both in the United States and internationally, with a market cap of approximately $3.69 billion.

Operations: The company generates revenue primarily from its data processing segment, which amounts to $4.78 billion.

Insider Ownership: 25.3%

Earnings Growth Forecast: 60.6% p.a.

Shift4 Payments shows potential for growth, with earnings forecast to grow significantly at 60.6% annually, despite recent volatility and lower profit margins compared to last year. The company's innovative Shift4 One product aims to drive incremental revenue by simplifying international transactions. Recent earnings reports indicate a substantial increase in sales but a decline in net income and EPS compared to the previous year. Insider ownership remains strong, supporting its strategic initiatives and market positioning.

Seize The Opportunity

• Take a closer look at our Fast Growing US Companies With High Insider Ownership list of 184 companies by clicking here.
• Seeking Other Investments? AI is about to change healthcare. These 133 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.